Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., . . . Franceschi, E. (2017). Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study. Oncotarget.
Citação norma ChicagoBrandes, Alba A., et al. "Early Tumour Shrinkage As a Survival Predictor in Patients With Recurrent Glioblastoma Treated With Bevacizumab in the AVAREG Randomized Phase II Study." Oncotarget 2017.
Citação norma MLABrandes, Alba A., et al. "Early Tumour Shrinkage As a Survival Predictor in Patients With Recurrent Glioblastoma Treated With Bevacizumab in the AVAREG Randomized Phase II Study." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.